We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nonaddictive Opioid Shows No Side Effects

By HospiMedica staff writers
Posted on 03 Dec 2001
An early clinical trial of a new opioid involving patients with the intractable pain of pancreatitis has shown that the drug is nonaddictive and relieves pain by acting only on peripheral nerves, thereby causing few or no side effects.

Morphine and other opioids work by affecting receptors in the brain, where the pain is experienced. More...
However, patients taking morphine are likely to become addicted to the pleasures of stimulation of the opioid receptors located in other parts of the brain. In addition, opioid receptors in other parts of the body are stimulated by the morphine, creating serious side effects such as respiratory depression, sedation, and gastrointestinal problems.

In contrast, the new opioid stimulates a different set of opioid receptors, called kappa receptors, found at the site of the injury. Called a kappa opioid receptor stimulator (ADL 10-0101), the drug treated pain before it reached the brain and thus caused no side effects. The developer, Adolor Corp. (Exton, PA, USA; www.adolor.com), states that the drug has no addiction potential and represents a safe way to treat pain so severe that no current medications can alleviate it.




Related Links:
Adolor

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.